AstraZeneca PLC (STO:AZN)

AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of SEK 2.34 trillion. The enterprise value is 2.58 trillion.

Market Cap	2.34T
Enterprise Value	2.58T

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	Aug 7, 2025

Share Statistics

Current Share Class	1.55B
Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.54B

Valuation Ratios

The trailing PE ratio is 29.67 and the forward PE ratio is 16.31.

PE Ratio	29.67
Forward PE	16.31
PS Ratio	4.36
PB Ratio	5.49
P/TBV Ratio	n/a
P/FCF Ratio	22.02
P/OCF Ratio	18.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.21, with an EV/FCF ratio of 24.30.

EV / Earnings	32.74
EV / Sales	4.89
EV / EBITDA	14.21
EV / EBIT	19.30
EV / FCF	24.30

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.74.

Current Ratio	0.86
Quick Ratio	0.66
Debt / Equity	0.74
Debt / EBITDA	1.69
Debt / FCF	2.95
Interest Coverage	10.77

Financial Efficiency

Return on equity (ROE) is 19.67% and return on invested capital (ROIC) is 11.88%.

Return on Equity (ROE)	19.67%
Return on Assets (ROA)	8.28%
Return on Invested Capital (ROIC)	11.88%
Return on Capital Employed (ROCE)	18.19%
Revenue Per Employee	5.70M
Profits Per Employee	836,482
Employee Count	94,300
Asset Turnover	0.52
Inventory Turnover	1.65

Taxes

In the past 12 months, AstraZeneca has paid 16.37 billion in taxes.

Income Tax	16.37B
Effective Tax Rate	17.17%

Stock Price Statistics

The stock price has decreased by -14.66% in the last 52 weeks. The beta is 0.15, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-14.66%
50-Day Moving Average	1,415.69
200-Day Moving Average	1,444.59
Relative Strength Index (RSI)	59.65
Average Volume (20 Days)	283,809

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of SEK 537.29 billion and earned 78.88 billion in profits. Earnings per share was 50.48.

Revenue	537.29B
Gross Profit	442.00B
Operating Income	136.47B
Pretax Income	95.31B
Net Income	78.88B
EBITDA	181.90B
EBIT	136.47B
Earnings Per Share (EPS)	50.48

Balance Sheet

The company has 67.59 billion in cash and 313.23 billion in debt, giving a net cash position of -245.64 billion.

Cash & Cash Equivalents	67.59B
Total Debt	313.23B
Net Cash	-245.64B
Net Cash Per Share	n/a
Equity (Book Value)	426.11B
Book Value Per Share	274.35
Working Capital	-43.71B

Cash Flow

In the last 12 months, operating cash flow was 127.32 billion and capital expenditures -21.04 billion, giving a free cash flow of 106.28 billion.

Operating Cash Flow	127.32B
Capital Expenditures	-21.04B
Free Cash Flow	106.28B
FCF Per Share	n/a

Margins

Gross margin is 82.26%, with operating and profit margins of 25.40% and 14.68%.

Gross Margin	82.26%
Operating Margin	25.40%
Pretax Margin	17.74%
Profit Margin	14.68%
EBITDA Margin	33.85%
EBIT Margin	25.40%
FCF Margin	19.78%

Dividends & Yields

This stock pays an annual dividend of 32.77, which amounts to a dividend yield of 2.14%.

Dividend Per Share	32.77
Dividend Yield	2.14%
Dividend Growth (YoY)	4.23%
Years of Dividend Growth	3
Payout Ratio	59.51%
Buyback Yield	-0.06%
Shareholder Yield	2.08%
Earnings Yield	3.37%
FCF Yield	4.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	6